Dr Anne Langsted, Rigshospitalet, Copenhagen, Denmark
In recent years, there has been an upsurge of interest in Lp(a) as a result of the growing body of research supporting the association between elevated Lp(a) and cardiovascular disease (CVD).
AstraZeneca has provided a sponsorship grant towards this independent programme.